Filter
843
Text search:
drug
toxicity
Featured
Recommendations
120
New Publications
213
Language
Document type
No document type
487
Guidelines
177
Studies & Reports
112
Manuals
38
Training Material
17
Fact sheets
8
Strategic & Response Plan
2
Situation Updates
1
Infographics
1
Countries / Regions
India
62
Kenya
27
Ethiopia
26
Global
21
South Africa
17
Nepal
15
Zambia
14
Tanzania
14
Uganda
11
Rwanda
11
Namibia
11
Ghana
9
Latin America and the Carribbean
9
Western and Central Europe
9
Sierra Leone
8
Philippines
8
Myanmar / Burma
8
Africa
7
Nigeria
6
Zimbabwe
6
Bangladesh
6
Eswatini/ Swaziland
6
Eastern Europe
6
Cambodia
5
Malawi
5
South–East Asia Region
5
Ukraine
4
Botswana
4
Lesotho
4
Asia
4
Liberia
3
USA
3
Thailand
3
Russia
3
South Sudan
2
Germany
2
Colombia
2
Western Pacific Region
2
Senegal
1
Congo, Democratic Republic of
1
Cameroon
1
Iraq
1
Syria
1
Gambia
1
Papua New Guinea
1
Brazil
1
North Macedonia
1
Bolivia
1
Angola
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
Fiji
1
Mongolia
1
Laos
1
Estonia
1
Iran
1
Australia
1
Georgia
1
North America
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
286
Clinical Guidelines
147
Public Health
34
Women & Child Health
32
Capacity Building
15
Key Resources
12
Pharmacy & Technologies
10
Toolboxes
HIV
137
TB
102
Mental Health
61
Pharmacy
53
NTDs
48
AMR
37
COVID-19
24
Caregiver
14
Planetary Health
13
Specific Hazards
9
NCDs
9
Rapid Response
8
Refugee
7
Malaria
7
Ebola & Marburg
6
Conflict
5
Global Health Education
5
Polio
4
Disability
2
2.0 Rapid Response
2
Natural Hazards
1
Zika
1
Health Financing Toolbox
1
Accessed December 2017
Amphetamine-type stimulants, new psychoactive substances
-4-
World Drug Report 2017
Accessed: 14.03.2019
Drug Distribution and Control: Preparation and Handling–Guidelines
Review 2008
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica
...
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Uptsate 2017
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organ
...
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant
tuberculosis (XDR-TB) increasingly occur in resource-constrained settings.
In the context of a national response to MDR- and XDR-TB, health workers in
TB clinics (in distric
...
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO, which considers Pharmacovigilance, an essential com
...
WHO operational handbook on tuberculosis: module 4: treatment: tuberculosis care and support
recommended
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis,
...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the dru
...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread
...
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International
...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a
...
Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
recommended
The recommendations in these guidelines promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment; prioritize treatment for those with most advanced liver disease and at greatest risk of mortality; and recommend the preferred use of n
...
hese are two parallel guidelines, one for small hospitals and another one for large hospitals. In view of heavy burden of malaria and prevalence of drug resistant falciparum malaria in the South-East Asia Region, the guidelines were developed for us
...
Following the encouraging initial results of the pilot project, the Ministry of Health is committed to increasing access to MDR-TB diagnosis, treatment and care. An expansion plan for the programmatic management of drug-resistant TB has been develop
...
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone refere
...
